Vico Therapeutics B.V.
- Address
- J.H. Oortweg 21
Sponsor Overview
Specializations
Neurodegenerative Disease
Vico Therapeutics B.V. focuses on clinical research in spinocerebellar ataxia type 1, spinocerebellar ataxia type 3, and Huntington’s disease, with attention to disorders marked by progressive motor and neurological impairment.
- Spinocerebellar ataxia type 1
- Spinocerebellar ataxia type 3
- Huntington’s disease
The sponsor’s research activity is centered on conditions affecting coordination, movement control, and neurological function.
Genetic Neurology
The clinical portfolio includes inherited neurological disorders associated with abnormal gene expression and progressive central nervous system dysfunction.
- Hereditary ataxia
- Polyglutamine disease
- Movement disorder
Research interest is directed toward diseases with shared genetic and neurodegenerative mechanisms.
Intrathecal Neurotherapeutics
Vico Therapeutics B.V. is engaged in studies of intrathecal administration for therapies delivered to the cerebrospinal fluid, reflecting a focus on direct treatment of neurological disease.
- Intrathecal delivery
- Lumbar administration
- Central nervous system targeting
This area links therapeutic development with neurological access strategies for disorders that require direct CNS exposure.
Neurological Biomarkers and Clinical Assessment
The sponsor’s trial activity includes evaluation of safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with manifest neurodegenerative disease.
- Safety assessment
- Tolerability evaluation
- Pharmacodynamic response
Clinical interest extends to measurable treatment effects in inherited neurological disorders.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecal VO659 in Spinocerebellar Ataxia Types 1, 3, and Huntington's Disease |  Denmark France Germany The Netherlands | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 13 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
13 centres- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- 4 Rue Larrey, 49100 Angers
- Address
- 80 Avenue Augustin Fliche, 34295 Montpellier
- Address
- Chariteplatz 1, 10117 Berlin
- Address
- Venusberg-Campus 1/99, Venusberg, 53127 Bonn
- Address
- 100 Boulevard Du General Leclerc, 92110 Clichy
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Vico Therapeutics B.V..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.